Impact of respiratory viral infections on cystic fibrosis

Postgraduate Medical Journal

Volumn 79, Issue 930, 2003, Pages 201-203

  Wat, Dennis ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIBIOTIC AGENT; OSELTAMIVIR; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RIBAVIRIN; RIMANTADINE; ZANAMIVIR;

ANTIBIOTIC THERAPY; CLINICAL PRACTICE; CYSTIC FIBROSIS; DISEASE ASSOCIATION; FEVER; HUMAN; INFLUENZA VIRUS; LIFE EXPECTANCY; LUNG FUNCTION; LUNG INFECTION; NEUTROPHILIA; PROGNOSIS; PROPHYLAXIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SURVIVAL; SYMPTOM; VIRUS INFECTION;

ADOLESCENT; BACTERIAL INFECTIONS; CYSTIC FIBROSIS; HUMANS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 0038189501     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.79.930.201     Document Type: Review

References (28)

1. Riodren JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characteristion of complementary DNA. Science 1989;245:1066-73.
2. Barasch J, Al-Awagti Q. Defective acidification of the biosynthetic pathway in cystic fibrosis. J Cell Sci 1993;17(suppl 1):229-33.
3. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991;46:881-5.
4. Mahadeva R, Webb K, Westerbeak RC, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis - a cross sectional study. BMJ 1998;316:1771-5.
5. Accurso FJ, Sokol RJ, Hammond KB, et al. Early respiratory course in infants with cystic fibrosis: relevance to newborn screening. Pediatr Pulmonol 1991;7:42-5.
6. Johnson SL, Paltemore PK, Sanderson G, et al. Community study of the role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225-8.
7. Gern JE, Williams WB. Association of rhinovirus infections with asthma. Clin Microbiol Rev 1999;12:9-18.
8. Freymouth F, Vabret A, Brouard J, et al. Detection of viral Chlamydia pneumoniae and mycoplasma pneumoniae infections in exacerbations of asthma. J Clin Virol 1999;13:131-9.
9. Wright PF, Khaw KT, Oxman MN, et al. Evaluation of the safety of amantadine-HC 1 and the role of respiratory viral infections in children with cystic fibrosis. J Infect Dis 1976;134:144-9.
10. Petersen NT, Hoiby N, Mordhorst CH, et al. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma; possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand 1981;70:628-8.
11. Wang EE, Prober CG, Manson B, et al. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med 1984;311:1653-8.
12. Abman SH, Ogle JW, Butlet SN, et al. Role of respiratory syncytial virus in early hospitalisation for respiratory distress of young infants with cystic fibrosis. J Pediatr 1988;113:826-30.
13. Ramsey BM, Gore EJ, Smith AL, et al. The effect of respiratory viral infections on patients with cystic fibrosis. Am J Dis Child 1989;143:662-8.
14. Smyth AR, Smyth RL, Tony CYW, et al. Effect of respiratory viral infections including rhinovirus in clinical status in cystic fibrosis. Arch Dis Child 1995;73:117-20.
15. Armstrong D, Grimwood K, Carlin JB, et al. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol 1998;26:371-9.
16. Freymouth F, Vabret A, Galateau-Salle F, et al. Detection of respiratory syncytial virus, parainfluenza virus, adenovirus and rhinovirus sequences in respiratory tract of infants y polymerase chain reaction and hybridisation. Clinical Diagnosis Virology 1997;8:31-40.
17. Ireland DC, Kent J, Nicholson KG. Improved detection of rhinovirus in nasal and throat swabs by semi-nested RT-PCR. J Med Virol 1993;40:96-101.
18. Collinson J, Nicholson KG, Cancio E, et al. Effects of respiratory tract infections in patients with cystic fibrosis. Thorax 1996;51:1115-22.
19. Ramirez-Randa CH, Fuxench-Lopez Z, Nevarez M, et al. Increased pharyngeal bacterial colonisation during viral illnesses. Arch Intern Med 1981;114:599-603.
20. Smith CB, Golden C, Klauber MR, et al. Interaction between viruses and bacteria in patients with chronic bronchitis. J Infect Dis 1976;134:552-61.
21. Armstrong DS, Grimwood K, Carlin JB, et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997; 156(4 pt 1):1197-204.
22. Niederman MS, Merrill WW, Ferrenti RD, et al. Nutritional status and bacterial binding in the lower respiratory tract in patients with chronic tracheostomy. Ann Intern Med 1984;100:795-800.
23. Przyklenk B, Bauernfeind A, Bertele RM, et al. Viral infections of the respiratory tract in patients with cystic fibrosis. Serodiagn Immunother Infect Dis 1988;2:217-25.
24. Kim HW, Canchola JG, Brandt CD, et al. Respiratory syncytial viral disease in infants despite prior administration of antigen inactivated vaccine. Am J Epidemiol 1969;89:422-34.
25. Wright PF, Khaw KT, Oxman MN, et al. Evaluation of the safety of amantadine-HC 1 and the role of respiratory viral infections in children with cystic fibrosis. J Infect Dis 1976;134:144-9.
26. Ratjen R. Changes in strategies for optimal antibacterial therapy in cystic fibrosis. Int J Antimicrob Agents 2001;17:93-6.
27. Mukhopadhyay S, Singh M, Cater JI, et al. Nebulised anti-pseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks. Thorax 1996;551:361-8.
28. Ramsay BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999;340:23-30.